Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 1,717 Less Arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -43,107 More Arrow -30,607 More Arrow -21,882
EBITDA -43,618 More Arrow -30,932 More Arrow -21,520
Total assets 35,409 More Arrow 73,432 Less Arrow 55,012
Current assets 24,241 More Arrow 66,770 Less Arrow 51,769
Current liabilities 13,924 Less Arrow 9,684 Less Arrow 4,588
Equity capital 21,485 More Arrow 63,748 Less Arrow 50,424
- share capital 735 Less Arrow 726 Less Arrow 655
Employees (average) 7 Equal arrow 7 More Arrow 9

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 60.7% More Arrow 86.8% More Arrow 91.7%
Turnover per employee 245 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -2510.6%
Return on assets (ROA) -121.7% More Arrow -41.7% More Arrow -39.8%
Current ratio 174.1% More Arrow 689.5% More Arrow 1128.4%
Return on equity (ROE) -200.6% More Arrow -48.0% More Arrow -43.4%
Change turnover 1,717 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -2 More Arrow 2
Chg. No. of employees % 0% Less Arrow -22% More Arrow 29%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.